Article
TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
Frontiers in immunology - 1 Jan 2021
Gagelmann Nico, Wolschke Christine, Klyuchnikov Evgeny, Christopeit Maximilian, Ayuk Francis, Kröger Nicolaus
Abstract excerpt
This analysis aimed to systematically review and synthesize the existing evidence regarding the outcome of tyrosine kinase inhibitor (TKI) maintenance therapy after allogeneic stem-cell transplantation for patients with FLT3-ITD-mutated acute myeloid leukemia (AML). We searched publicly available databases, references lists of relevant reviews, registered trials, and relevant conference proceedings. A total of 7...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
